Efficacy of Erector Spinae Plane Block Analgesia After Off Pump Cardiac Surgery
ESPB
1 other identifier
interventional
50
1 country
1
Brief Summary
In this study the investigators will investigate the efficacy of ESPB as a part of Enhanced recovery after surgery on postoperative analgesia and recovery criteria after off pump cardiac surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable postoperative-pain
Started Mar 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 12, 2023
CompletedFirst Posted
Study publicly available on registry
March 15, 2023
CompletedStudy Start
First participant enrolled
March 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 10, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 25, 2023
CompletedMarch 19, 2024
March 1, 2024
7 months
February 12, 2023
March 17, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Total intraoperative and postoperative opioid consumption
Microgram and mg
48 hours
Secondary Outcomes (10)
pain intensity at rest and movement
48 hours
time to first rescue analgesia
24hous
Duration of mechanical ventilation
24 hours
time to extubation
24hours
time to ambulation
24hours
- +5 more secondary outcomes
Study Arms (2)
Erector spinae block group
ACTIVE COMPARATORthe patients will be administered bilateral Erector spinae block with 20 ml of 0.25 % bupivacaine
control group
OTHERno block will be done but only IV analgesia.
Interventions
After induction, the patients will be administered bilateral Erector spinae block with 20 ml of 0.25 % bupivacaine
fentanyl boluses of 0.5-to-1 µg/kg titrated according to haemodynamic parameters.
Eligibility Criteria
You may qualify if:
- age 18-70 years
- ejection fraction of \> 45%
- undergoing elective off-pump cardiopulmonary bypass surgery
You may not qualify if:
- vertebral anomalies
- intra-aortic balloon pump in the preoperative period
- acute myocardial infarction
- local infection at the site of block
- allergy to the local anesthetic used
- morbid obesity, psychiatric disorders, neurologic deficits, alcohol and chronic opioid abuse, and patients with bleeding diathesis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Menoufia university
Cairo, Shibin Elkom, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Islam M ElDesoky, MD
Menoufia University
- PRINCIPAL INVESTIGATOR
AMAL G SAFAN, MD
Menoufia University
- PRINCIPAL INVESTIGATOR
Abd-Elazeem A Elbakry, MD
Menoufia University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer of anaethesia
Study Record Dates
First Submitted
February 12, 2023
First Posted
March 15, 2023
Study Start
March 22, 2023
Primary Completion
October 10, 2023
Study Completion
December 25, 2023
Last Updated
March 19, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share